{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T09:49:44Z","timestamp":1791971384771,"version":"4.3.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-026-04287-1","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:43:14Z","timestamp":1791826994000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Oral eplerenone in first-episode acute central serous chorioretinopathy: results of a double-masked randomized trial"],"prefix":"10.1007","volume":"46","author":[{"given":"Ghodsieh","family":"Zamani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roozbeh","family":"Asghari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasser","family":"shoeibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Abrishami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyedeh Maryam","family":"Hoseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad-Reza","family":"Ansari-Astaneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojtaba","family":"Abrishami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Bakhtiari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrdad","family":"Motamed Shariati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,12]]},"reference":[{"issue":"3","key":"4287_CR1","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/ceo.14201","volume":"51","author":"AT Fung","year":"2023","unstructured":"Fung AT, Yang Y, Kam AW (2023) Central serous chorioretinopathy: a review. Clin Experiment Ophthalmol 51(3):243\u2013270","journal-title":"Clin Experiment Ophthalmol"},{"issue":"1","key":"4287_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s40662-023-00349-y","volume":"10","author":"X Zhang","year":"2023","unstructured":"Zhang X, Lim CZF, Chhablani J, Wong YM (2023) Central serous chorioretinopathy: updates in the pathogenesis, diagnosis and therapeutic strategies. Eye Vis (Lond) 10(1):33","journal-title":"Eye Vis (Lond)"},{"issue":"1","key":"4287_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s40942-023-00443-2","volume":"9","author":"A Zarnegar","year":"2023","unstructured":"Zarnegar A, Ong J, Matsyaraja T, Arora S, Chhablani J (2023) Pathomechanisms in central serous chorioretinopathy: a recent update. Int J Retina Vitreous 9(1):3","journal-title":"Int J Retina Vitreous"},{"issue":"5","key":"4287_CR4","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/s41433-021-01808-3","volume":"36","author":"P Kanda","year":"2022","unstructured":"Kanda P, Gupta A, Gottlieb C, Karanjia R, Coupland SG, Bal MS (2022) Pathophysiology of central serous chorioretinopathy: a literature review with quality assessment. Eye (Lond) 36(5):941\u2013962","journal-title":"Eye (Lond)"},{"issue":"5","key":"4287_CR5","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s10384-024-01101-2","volume":"68","author":"H Koizumi","year":"2024","unstructured":"Koizumi H, Imanaga N, Terao N (2024) Central serous chorioretinopathy and the sclera: what we have learned so far. Jpn J Ophthalmol 68(5):419\u2013428","journal-title":"Jpn J Ophthalmol"},{"key":"4287_CR6","doi-asserted-by":"crossref","unstructured":"Zhong Y, Liu W, Cao Y, Jin E (2025) Central serous chorioretinopathy: pathogenesis, diagnosis, and treatment","DOI":"10.61474\/ncs.2025.00007"},{"key":"4287_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2025.111777","author":"F Behar-Cohen","year":"2025","unstructured":"Behar-Cohen F (2025) A diametrically opposed view of the role of glucocorticoids in central serous chorioretinopathy. Med Hypotheses. https:\/\/doi.org\/10.1016\/j.mehy.2025.111777","journal-title":"Med Hypotheses"},{"issue":"13","key":"4287_CR8","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.1111\/bph.15770","volume":"179","author":"F Behar\u2010Cohen","year":"2022","unstructured":"Behar\u2010Cohen F, Zhao M (2022) Mineralocorticoid pathway in retinal health and diseases. Br J Pharmacol 179(13):3190\u20133204","journal-title":"Br J Pharmacol"},{"issue":"4","key":"4287_CR9","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1038\/s41433-020-01338-4","volume":"35","author":"J Duan","year":"2021","unstructured":"Duan J, Zhang Y, Zhang M (2021) Efficacy and safety of the mineralocorticoid receptor antagonist treatment for central serous chorioretinopathy: a systematic review and meta-analysis. Eye 35(4):1102\u20131110","journal-title":"Eye"},{"issue":"6","key":"4287_CR10","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1007\/s40123-023-00816-8","volume":"12","author":"P Viggiano","year":"2023","unstructured":"Viggiano P, Boscia G, Borrelli E, Toto L, Grassi MO, Evangelista F et al (2023) Choriocapillaris reperfusion in resolved chronic central serous chorioretinopathy treated with eplerenone: long-term effects on the fellow eye. Ophthalmol Ther 12(6):3199\u20133210","journal-title":"Ophthalmol Ther"},{"key":"4287_CR11","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ajo.2025.06.012","volume":"278","author":"RS Huang","year":"2025","unstructured":"Huang RS, Mihalache A, Benour A, Zaman M, Popovic MM, Kertes PJ et al (2025) Eplerenone and spironolactone for chronic central serous chorioretinopathy: a systematic review and meta-analysis: eplerenone and spironolactone for CSCR. Am J Ophthalmol 278:22\u201337","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"4287_CR12","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1097\/IAE.0000000000004024","volume":"44","author":"RA Kaye","year":"2024","unstructured":"Kaye RA, Peto T, Hogg R, Griffiths H, Sivaprasad S, Lotery AJ (2024) Choroidal vascularity in chronic central serous chorioretinopathy and its association with risk single-nucleotide polymorphisms. Retina 44(5):837\u2013843","journal-title":"Retina"},{"issue":"2","key":"4287_CR13","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41433-018-0212-2","volume":"33","author":"A Willcox","year":"2019","unstructured":"Willcox A, Culliford L, Ellis L, Rogers CA, Cree A, Chakravarthy U et al (2019) Clinical efficacy of eplerenone versus placebo for central serous chorioretinopathy: study protocol for the VICI randomised controlled trial. Eye (Lond) 33(2):295\u2013303","journal-title":"Eye (Lond)"},{"issue":"16","key":"4287_CR14","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.1038\/s41433-023-02509-9","volume":"37","author":"SR Singh","year":"2023","unstructured":"Singh SR, Got\u00e9 JT, Chhablani J (2023) Randomized controlled trials in central serous chorioretinopathy: a review. Eye 37(16):3306\u20133312","journal-title":"Eye"},{"key":"4287_CR15","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.preteyeres.2015.05.003","volume":"48","author":"A Daruich","year":"2015","unstructured":"Daruich A, Matet A, Dirani A, Bousquet E, Zhao M, Farman N et al (2015) Central serous chorioretinopathy: recent findings and new physiopathology hypothesis. Prog Retin Eye Res 48:82\u2013118","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"4287_CR16","doi-asserted-by":"publisher","first-page":"61","DOI":"10.4103\/joco.joco_13_22","volume":"36","author":"M Akhlaghi","year":"2024","unstructured":"Akhlaghi M, Dehghani A, Kianersi F, Khalili MR, Tohidi M, Jahanbani-Ardakani H (2024) Effect of eplerenone treatment in patients with central serous retinopathy: a double-blind randomized clinical trial. J Curr Ophthalmol 36(1):61","journal-title":"J Curr Ophthalmol"},{"key":"4287_CR17","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S220845","author":"F Semeraro","year":"2019","unstructured":"Semeraro F, Morescalchi F, Russo A, Gambicorti E, Pilotto A, Parmeggiani F et al (2019) Central serous chorioretinopathy: pathogenesis and management. Clin Ophthalmol. https:\/\/doi.org\/10.2147\/OPTH.S220845","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"4287_CR18","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.survophthal.2012.07.004","volume":"58","author":"B Nicholson","year":"2013","unstructured":"Nicholson B, Noble J, Forooghian F, Meyerle C (2013) Central serous chorioretinopathy: update on pathophysiology and treatment. Surv Ophthalmol 58(2):103\u2013126","journal-title":"Surv Ophthalmol"},{"issue":"5","key":"4287_CR19","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1097\/IAE.0000000000001649","volume":"38","author":"E Rahimy","year":"2018","unstructured":"Rahimy E, Pitcher JD III, Hsu J, Adam MK, Shahlaee A, Samara WA et al (2018) A randomized double-blind placebo-control pilot study of eplerenone for the treatment of central serous chorioretinopathy (ecselsior). Retina 38(5):962\u2013969","journal-title":"Retina"},{"issue":"2","key":"4287_CR20","first-page":"310","volume":"8","author":"RP Singh","year":"2015","unstructured":"Singh RP, Sears JE, Bedi R, Schachat AP, Ehlers JP, Kaiser PK (2015) Oral eplerenone for the management of chronic central serous chorioretinopathy. Int J Ophthalmol 8(2):310","journal-title":"Int J Ophthalmol"},{"issue":"4","key":"4287_CR21","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3928\/23258160-20150422-06","volume":"46","author":"DA Salz","year":"2015","unstructured":"Salz DA, Pitcher IIIJD, Hsu J, Regillo CD, Fineman MS, Elliott KS et al (2015) Oral eplerenone for treatment of chronic central serous chorioretinopathy: a case series. Ophthalmic Surg Lasers Imaging Retina 46(4):439\u2013444","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"4","key":"4287_CR22","first-page":"67","volume":"1","author":"L Siaudvytyte","year":"2012","unstructured":"Siaudvytyte L, Diliene V, Miniauskiene G, Balciuniene VJ (2012) Photodynamic therapy and central serous chorioretinopathy. Med Hypothesis Discov Innov Ophthalmol 1(4):67\u201371","journal-title":"Med Hypothesis Discov Innov Ophthalmol"},{"issue":"12","key":"4287_CR23","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1038\/s41433-022-02370-2","volume":"37","author":"S Khandhadia","year":"2023","unstructured":"Khandhadia S, Thulasidharan S, Hoang NTV, Ibrahim SA, Ouyang Y, Lotery A (2023) Real world outcomes of photodynamic therapy for chronic central serous chorioretinopathy. Eye (Lond) 37(12):2548\u20132553","journal-title":"Eye (Lond)"},{"key":"4287_CR24","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ajo.2021.06.020","volume":"233","author":"TJ van Rijssen","year":"2022","unstructured":"van Rijssen TJ, van Dijk EHC, Tsonaka R, Feenstra HMA, Dijkman G, Peters PJH et al (2022) Half-dose photodynamic therapy versus eplerenone in chronic central serous chorioretinopathy (SPECTRA): a randomized controlled trial. Am J Ophthalmol 233:101\u2013110","journal-title":"Am J Ophthalmol"},{"key":"4287_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/bmjophth-2023-001310","author":"M Palakkamanil","year":"2023","unstructured":"Palakkamanil M, Munro M, Sethi A, Adatia F (2023) Intravitreal anti-vascular endothelial growth factor for the treatment of chronic central serous retinopathy: a meta-analysis of the literature. BMJ Open Ophthalmol. https:\/\/doi.org\/10.1136\/bmjophth-2023-001310","journal-title":"BMJ Open Ophthalmol"},{"key":"4287_CR26","first-page":"1272524","volume":"2022","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Zhang J, Sun X (2022) The efficacy of anti-VEGF therapy for putative or visible CNV in central serous chorioretinopathy by optical coherence tomography angiography. J Ophthalmol 2022:1272524","journal-title":"J Ophthalmol"},{"key":"4287_CR27","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.ajo.2025.04.005","volume":"276","author":"P Viggiano","year":"2025","unstructured":"Viggiano P, Moscara F, Termite AC, Boscia G, La Terza M, Salvelli A et al (2025) Choroidal layer analysis under flat irregular pigment epithelial detachments in central serous chorioretinopathy. Am J Ophthalmol 276:210\u2013217","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"4287_CR28","doi-asserted-by":"publisher","first-page":"394","DOI":"10.4103\/2211-5056.362040","volume":"12","author":"JB Park","year":"2022","unstructured":"Park JB, Kim K, Kang MS, Kim ES, Yu S-Y (2022) Central serous chorioretinopathy: treatment. Taiwan J Ophthalmol 12(4):394\u2013408","journal-title":"Taiwan J Ophthalmol"},{"issue":"4","key":"4287_CR29","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1080\/17469899.2024.2336241","volume":"19","author":"M Borselli","year":"2024","unstructured":"Borselli M, Rossi C, Chisari D, Carnovale Scalzo G, Lucisano A, Randazzo G et al (2024) Current and emerging treatment options for central serous chorioretinopathy. Expert Rev Ophthalmol 19(4):247\u2013260","journal-title":"Expert Rev Ophthalmol"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-026-04287-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-026-04287-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-026-04287-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T09:03:29Z","timestamp":1791968609000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-026-04287-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,12]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4287"],"URL":"https:\/\/doi.org\/10.1007\/s10792-026-04287-1","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,12]]},"assertion":[{"value":"7 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study followed the Declaration of Helsinki and was approved by the institutional review board and ethics committee of the Mashhad University of Medical Sciences (approval number: IR.MUMS.MEDICAL.REC.1398.475, RCT code: IRCT20191116045458N1).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was acquired from all patients.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent for publication was acquired from the patients.","order":4,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"417"}}